Track Apyx Medical's total liabilities ($50M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), APYX shows a total liabilities of $50M. That compares with $51M in the prior-year period — down 1.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, APYX's total liabilities is now $50M (was $51M) — a 1.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Apyx Medical is outperforming or lagging.
Tracking APYX's total liabilities over time shows whether Apyx Medical is scaling, shrinking, or reshaping that part of the business. The current reading is $50M That compares with $51M in the prior-year period — down 1.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has Apyx Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $50M) with ownership activity and broader fundamentals.
Apyx Medical's total liabilities is $50M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.